A pooled analysis of individual patient data (IPD) of concurrent chemoradiotherapy for limited-stage small cell lung cancer (LS-SCLC) in elderly compared to younger patients (pts) who participated in US National Cancer Institute cooperative group studies
Year: 2018
Type: article
Abstract: Background: Platinum and etoposide with concurrent thoracic radiation is the standard treatment for LS-SCLC. Elderly pts are common, and may experience higher rates of adverse events (AEs) and have a worse outcome from this treatment.
Source: Annals of Oncology
Authors: T.E. Stinchcombe, W. Fan, S.E. Schild, E.E. Vokes, J. Bogart, Q.-T.X. Le, C.R. Thomas, M. Edelman, L. Horn, R. Komaki, H.J. Cohen, A.K. Ganti, H. Pang, X. Wang
Institutions: Duke Medical Center, Duke Cancer Institute, Duke University, Mayo Clinic in Arizona, University of Chicago, University of Chicago Medical Center, SUNY Upstate Medical University, Stanford Medicine, Stanford University, Oregon Health & Science University, Fox Chase Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, The University of Texas MD Anderson Cancer Center, Nebraska Medical Center, University of Nebraska Medical Center, University of Hong Kong
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,080
OpenAlex ID: W2898221615